| Time | Session |
|---|
|
10:45
20:00
|
Three- dimensional (3D) Cancer Microenvironment that Confers Chemoresistance to DNA Damaging Drug
P-291
EACR25-0208
Jue Shi
Poster Presenter
Hong Kong, China
|
Targeted Delivery of NVPBEZ235 conjugated to gold nanoparticles for Overcoming Gemcitabine Resistance in Triple-Negative Breast Cancer
P-292
EACR25-0218
_uranur Ayvaz
Poster Presenter
Turkey
|
In Silico Identification of Common Pre-existing Resistance Mechanisms to EGFR Inhibitors in Colorectal Cancer
P-293
EACR25-0278
Carlos Fernandez-Lozano
Poster Presenter
Spain
|
A newly discovered mTOR-STAT3 pathway regulates calcium release and calcium-mediated apoptosis at the ER in Triple Negative Breast Cancer
P-295
EACR25-0456
Daniele Viavattene
Poster Presenter
Italy
|
Evaluate the potential sensitization effect and underlying mechanism of tyrosine kinase inhibitor on cisplatin resistance oral squamous cell carcinoma
P-296
EACR25-0566
Ying-Tzu Chen
Poster Presenter
Taiwan
|
Study of long non-coding RNAs in resistance to KRAS G12C inhibitors in lung cancers
P-297
EACR25-0574
Thomas PAPAZYAN
Poster Presenter
France
|
Targeting the Non-Homologous End-Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin-Induced Senescence in a p53-dependent Manner
P-298
EACR25-0592
Thijs Jalving
Poster Presenter
Netherlands
|
Regulation of FOXK2 by AKT in breast cancer cells: Serine 398 as a novel potential phosphorylation site
P-299
EACR25-0598
Luciana da Torre Carneiro
Poster Presenter
Brazil
|
FOXK2 transcription factor in cancer: expression, function and potential as a biomarker
P-300
EACR25-0600
Renata Ivo Vasconcelos
Poster Presenter
Brazil
|
Targeting low fidelity polymerases to prevent acquired resistance mutations to EGFR-targeted therapy in lung cancer.
P-301
EACR25-0764
Marieke Van Daele
Poster Presenter
Israel
|
Inhibition of the extracellular signal-regulated kinase 5 (ERK5) increases EGFR expression and its nuclear localization in HCC, generating new targeting opportunities
P-302
EACR25-0984
Alessio Menconi
Poster Presenter
Italy
|
mTORC1 Fuels Resistance but Unlocks Metabolic Kill-Switch in PI3K-Mutant Breast Cancer
P-303
EACR25-1238
Alina Stroh
Poster Presenter
Germany
|
Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies
P-304
EACR25-1298
Christa Dijkhuizen
Poster Presenter
Netherlands
|
Discovery of Molecular and Epigenetic Candidates Underlying Chemoresistance of Colorectal Cancer
P-305
EACR25-1344
Saba Selvi
Poster Presenter
Czech Republic
|
The mechanism of PPARα-mediated cholesterol metabolism in regulating paclitaxel resistance in ovarian cancer cells
P-306
EACR25-1350
Mingzhuo Chen
Poster Presenter
China
|
AP-1 transcription factor is a targetable mediator of osimertinib resistance in EGFR-mutant non-small cell lung cancer
P-307
EACR25-1424
Sude Eris
Poster Presenter
Turkey
|
Overactivation of oncogenic signaling steers cancer cells toward less malignant phenotypes
P-308
EACR25-1446
Chrysa Papagianni
Poster Presenter
Netherlands
|
CIC: The Master Regulator of Resistance to MAPK Pathway Inhibition
P-309
EACR25-1480
Joao Neto
Poster Presenter
Netherlands
|
Unlocking New Therapies: Targeting GSDMB Overexpression in HER2-Positive Tumors
P-310
EACR25-1572
Carmen Ramos Nebot
Poster Presenter
Spain
|
FGFR signaling as a key mediator of resistance to alpelisib/fulvestrant combination in PIK3CA-mutant luminal A breast cancer
P-311
EACR25-1592
Melda Ozge Oguz
Poster Presenter
Turkey
|
Targeting Ferroptosis to Enhance the Efficacy of BRAF/MEK Inhibitors in Overcoming Resistance in Melanoma
P-312
EACR25-1612
Juan Antonio Fafian Labora
Poster Presenter
Spain
|
Investigation of the expression of drug resistance genes after Sorafenib administration
P-313
EACR25-1622
IPEK ECE KOCKAR
Poster Presenter
Turkey
|
Targeting CCL19/21-CCR7 axis to overcome resistance to ALK inhibitors in ALK+ lymphoma
P-314
EACR25-1644
Mariapia Russo
Poster Presenter
Italy
|
T-cell receptor (TCR) diversity in buffy coat samples from blood of ovarian, vulvar squamous cell and cervical cancer patients
P-294
EACR25-1656
Corinna Keup
Poster Presenter
Germany
|
Genomic Instability and Epigenomic Dysregulation as Hallmarks of mCRC Therapy Resistance — Findings from Broad ctDNA Molecular Profiling (METACC)
P-315
EACR25-1664
Camblor Daniel G.
Poster Presenter
Spain
|
Exploring potential strategies overcoming the PARPi resistance in the Olaparib induced MDA-MB-436 resistant model
P-316
EACR25-1698
FEIFEI FEI FAN
Poster Presenter
China
|
BMI1 as a therapeutic target to overcome chemoresistance in high-grade serous ovarian cancer
P-317
EACR25-1980
Sadia Zafar
Poster Presenter
Finland
|
Identification of microRNAs and their target genes associated with acquired resistance of primary melanoma cells to targeted therapy
P-318
EACR25-2034
Ignacija Vla_i_
Poster Presenter
Croatia
|
Impact of Mechanical Stress and Confinement on the Alteration of Protein Expression and Emergence of Time-Dependent Resistance to Cisplatin
P-319
EACR25-2042
Yasmin Antonelli
Poster Presenter
Germany
|
Uncovering Transcriptional Signatures of Differential Drug Response in Archetypical Malignant States in Metastatic Breast Cancer (MBC)
P-320
EACR25-2062
Hodaya Haimov
Poster Presenter
Israel
|
Overcoming P-glycoprotein-mediated resistance in tumor cells through copolymers for cytotoxic drug delivery
P-321
EACR25-2102
Milada _
Poster Presenter
Czech Republic
|
Dual targeting BRD4-CDK9 transcriptional complex as a potent therapeutic strategy in glioblastoma
P-322
EACR25-2108
Raquel L
Poster Presenter
Spain
|
Unraveling mechanisms of CDK4/6 inhibitors resistance in metastatic breast cancer
P-323
EACR25-2112
Irina Suheila Fonseca
Poster Presenter
Spain
|
Immune infiltration is associated with favorable response to neoadjuvant chemotherapy and carboplatin in hormone receptor positive and triple negative breast cancer
P-324
EACR25-2246
Eivind Valen Egeland
Poster Presenter
Norway
|
Inhibition of the RNA-binding protein HuR reduces cell proliferation and promotes apoptosis in EGFR-TKI resistant NSCLC cells
P-325
EACR25-2270
Annarita Cascone
Poster Presenter
Italy
|
Targeting PI3K/AKT Pathway Dysregulation in Triple-Negative Breast Cancer: Overcoming Alpelisib Resistance through Dual Inhibition
P-326
EACR25-2322
Grace Colley
Poster Presenter
Ireland
|
Endothelial-Derived CAFs Drive Chemoresistance via ERCC1-IL-17A Axis: A Novel Therapeutic Target in Tumour Microenvironment
P-327
EACR25-2390
Katarzyna Sobierajska
Poster Presenter
Poland
|
miR-181a-5p and Caveolin-1 Express Inversely in HCC and Augment the Aggressive Phenotype of Sorafenib-Resistant HCC Cells
P-328
EACR25-2410
Ezgi Bagirsakci
Poster Presenter
Turkey
|
Overcoming Taxane Resistance Through PRMT5 Inhibition: Targeting Epigenetic Mechanisms
P-329
EACR25-2458
Ezgi Karyemez
Poster Presenter
Turkey
|
Unraveling tumor intrinsic responses: IFN-gamma predicts clinical immunotherapy efficacy and exclusively triggers apoptosis in solid tumors while sparing hematologic malignancies
P-330
EACR25-2546
Iris Garrido-Cano
Poster Presenter
Spain
|
Signaling Pathways affected by RAGE inhibition in vemurafenib treated melanoma cells
P-331
EACR25-2550
Estelle Leclerc
Poster Presenter
United States
|
Berberine, a P-glycoprotein inhibitor, shows synergistic anti-cancer effect when combined with Dactolisib in Colorectal Carcinoma HCT116 cell lines
P-332
EACR25-2572
Zeynep Busra Bolat
Poster Presenter
Turkey
|
ELUCIDATING TOPOTECAN-RESISTANCE MECHANISM IN HUMAN BREAST MCF-7 CANCER CELLS AND PACLITAXEL CROSS-RESISTANCE BY DNA DAMAGE SIGNALING PATHWAY GENE EXPRESSION.
P-332A
EACR25-24950
Erika Guerrero
Poster Presenter
Panama
|